• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4609573)   Today's Articles (108)   Subscriber (49378)
For: Gustafsson D. Oral direct thrombin inhibitors in clinical development. J Intern Med 2003;254:322-34. [PMID: 12974871 DOI: 10.1046/j.1365-2796.2003.01225.x] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Number Cited by Other Article(s)
1
Zeng YY, Zhang M, Ko S, Chen F. An Update on Cardiovascular Risk Factors After Kawasaki Disease. Front Cardiovasc Med 2021;8:671198. [PMID: 33937365 PMCID: PMC8086797 DOI: 10.3389/fcvm.2021.671198] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Accepted: 03/22/2021] [Indexed: 12/12/2022]  Open
2
Farcaş E, Hanson J, Pochet L, Fillet M. Capillary electrophoretic mobility shift displacement assay for the assessment of weak drug-protein interactions. Anal Chim Acta 2018;1034:214-222. [DOI: 10.1016/j.aca.2018.06.024] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2018] [Revised: 06/04/2018] [Accepted: 06/08/2018] [Indexed: 10/14/2022]
3
Shi K, Damhofer H, Daalhuisen J, Ten Brink M, Richel DJ, Spek CA. Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice. Mol Med 2017;23:13-23. [PMID: 28182192 DOI: 10.2119/molmed.2016.00214] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2016] [Accepted: 01/24/2017] [Indexed: 01/05/2023]  Open
4
Dobesh PP, Kim K, Stacy Z. The Future of Anticoagulation. J Pharm Pract 2016. [DOI: 10.1177/0897190004271777] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
5
Ren Y, Wu H, Lai F, Yang M, Li X, Tang Y. Isolation and identification of a novel anticoagulant peptide from enzymatic hydrolysates of scorpion (Buthus martensii Karsch) protein. Food Res Int 2014;64:931-938. [PMID: 30011736 DOI: 10.1016/j.foodres.2014.08.031] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2014] [Revised: 08/03/2014] [Accepted: 08/24/2014] [Indexed: 11/30/2022]
6
Kwaan HC, Samama MM. Anticoagulant drugs: an update. Expert Rev Cardiovasc Ther 2014;2:511-22. [PMID: 15225111 DOI: 10.1586/14779072.2.4.511] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
7
Halperin JL. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor. Expert Rev Cardiovasc Ther 2014;2:163-74. [PMID: 15151465 DOI: 10.1586/14779072.2.2.163] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
8
Weimar C, Diener HC. What’s new in stroke prevention and treatment. Expert Rev Neurother 2014;6:185-93. [PMID: 16466298 DOI: 10.1586/14737175.6.2.185] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
9
Rautio J. Prodrug Strategies in Drug Design. PRODRUGS AND TARGETED DELIVERY 2011. [DOI: 10.1002/9783527633166.ch1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
10
Van Huis CA, Casimiro-Garcia A, Bigge CF, Cody WL, Dudley DA, Filipski KJ, Heemstra RJ, Kohrt JT, Leadley RJ, Narasimhan LS, McClanahan T, Mochalkin I, Pamment M, Thomas Peterson J, Sahasrabudhe V, Schaum RP, Edmunds JJ. Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action. Bioorg Med Chem 2009;17:2501-11. [PMID: 19231206 DOI: 10.1016/j.bmc.2009.01.063] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2008] [Revised: 01/22/2009] [Accepted: 01/26/2009] [Indexed: 11/27/2022]
11
English J, Smith W. Cardio-embolic stroke. HANDBOOK OF CLINICAL NEUROLOGY 2009;93:719-749. [PMID: 18804677 DOI: 10.1016/s0072-9752(08)93036-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
12
Weitz JI, Hirsh J, Samama MM. New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:234S-256S. [PMID: 18574267 DOI: 10.1378/chest.08-0673] [Citation(s) in RCA: 190] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]  Open
13
Sandros MG, Sarraf CB, Tabrizian M. Prodrugs in cardiovascular therapy. Molecules 2008;13:1156-78. [PMID: 18560335 PMCID: PMC6245309 DOI: 10.3390/molecules13051156] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2008] [Revised: 05/14/2008] [Accepted: 05/14/2008] [Indexed: 11/27/2022]  Open
14
Wong PC, Crain EJ, Xin B, Wexler RR, Lam PYS, Pinto DJ, Luettgen JM, Knabb RM. Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies. J Thromb Haemost 2008;6:820-9. [PMID: 18315548 DOI: 10.1111/j.1538-7836.2008.02939.x] [Citation(s) in RCA: 219] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
15
Umer Usman MH, Raza S, Raza S, Ezekowitz M. Advancement in antithrombotics for stroke prevention in atrial fibrillation. J Interv Card Electrophysiol 2008;22:129-37. [PMID: 18425569 DOI: 10.1007/s10840-008-9210-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/23/2007] [Accepted: 01/11/2008] [Indexed: 11/24/2022]
16
Connolly SJ, Eikelboom J, O'Donnell M, Pogue J, Yusuf S. Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation. Circulation 2007;116:449-55. [PMID: 17646595 DOI: 10.1161/circulationaha.107.695163] [Citation(s) in RCA: 68] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
17
McRae SJ, Eikelboom JW. Latest medical treatment strategies for venous thromboembolism. Expert Opin Pharmacother 2007;8:1221-33. [PMID: 17563258 DOI: 10.1517/14656566.8.9.1221] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
18
Dunér K, Bäckström J, Magnell N, Svennberg H, Ahnoff M, Logren U. Determination of ximelagatran, melagatran and two intermediary metabolites in plasma by mixed-mode solid phase extraction and LC–MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852:317-24. [PMID: 17296338 DOI: 10.1016/j.jchromb.2007.01.035] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2006] [Revised: 01/16/2007] [Accepted: 01/21/2007] [Indexed: 10/23/2022]
19
Wienen W, Stassen JM, Priepke H, Ries UJ, Hauel N. Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis. J Thromb Haemost 2007;5:1237-42. [PMID: 17362226 DOI: 10.1111/j.1538-7836.2007.02526.x] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
20
Weitz JI, Linkins LA. Beyond heparin and warfarin: the new generation of anticoagulants. Expert Opin Investig Drugs 2007;16:271-82. [PMID: 17302522 DOI: 10.1517/13543784.16.3.271] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
21
Dorani H, Schützer KM, Sarich TC, Wall U, Logren U, Ohlsson L, Eriksson UG. Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers. Eur J Clin Pharmacol 2007;63:571-81. [PMID: 17387462 DOI: 10.1007/s00228-007-0292-6] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2007] [Accepted: 02/27/2007] [Indexed: 01/11/2023]
22
Campisi C, Biffi R, Pittiruti M. Catheter-Related Central Venous Thrombosis: The Development of a Nationwide Consensus Paper in Italy. ACTA ACUST UNITED AC 2007. [DOI: 10.2309/java.12-1-10] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
23
Wiviott SD, Giugliano RP. Non ST-Elevation Acute Coronary Syndromes. Cardiovasc Ther 2007. [DOI: 10.1016/b978-1-4160-3358-5.50016-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]  Open
24
Chackalamannil S. Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects. J Med Chem 2006;49:5389-403. [PMID: 16942011 DOI: 10.1021/jm0603670] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
25
Toomey JR, Abboud MA, Valocik RE, Koster PF, Burns-Kurtis CL, Pillarisetti K, Danoff TM, Erhardt JA. A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis. J Thromb Haemost 2006;4:1989-96. [PMID: 16961606 DOI: 10.1111/j.1538-7836.2006.02064.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
26
Olshansky B, Guo H. Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits. Expert Rev Cardiovasc Ther 2006;3:571-90. [PMID: 16076269 DOI: 10.1586/14779072.3.4.571] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
27
Bates SM, Weitz JI. The status of new anticoagulants. Br J Haematol 2006;134:3-19. [PMID: 16803562 DOI: 10.1111/j.1365-2141.2006.06134.x] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
28
Kwok L, Molckovsky D, Boucher M. Ximelagatran: a new type of oral anticoagulant. Int J Technol Assess Health Care 2005;21:480-6. [PMID: 16262971 DOI: 10.1017/s026646230505066x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
29
Bode W. The structure of thrombin, a chameleon-like proteinase. J Thromb Haemost 2005;3:2379-88. [PMID: 15892855 DOI: 10.1111/j.1538-7836.2005.01356.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
30
Christersson C, Oldgren J, Bylock A, Wallentin L, Siegbahn A. Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction. J Thromb Haemost 2005;3:2245-53. [PMID: 16194202 DOI: 10.1111/j.1538-7836.2005.01557.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
31
Weitz JI, Bates SM. New anticoagulants. J Thromb Haemost 2005;3:1843-53. [PMID: 16102051 DOI: 10.1111/j.1538-7836.2005.01374.x] [Citation(s) in RCA: 109] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
32
Linkins LA, Weitz JI. New anticoagulant therapy. Annu Rev Med 2005;56:63-77. [PMID: 15660502 DOI: 10.1146/annurev.med.56.082103.104708] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
33
Carruthers VB, Blackman MJ. A new release on life: emerging concepts in proteolysis and parasite invasion. Mol Microbiol 2005;55:1617-30. [PMID: 15752188 DOI: 10.1111/j.1365-2958.2005.04483.x] [Citation(s) in RCA: 80] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
34
Kam PCA, Kaur N, Thong CL. Direct thrombin inhibitors: pharmacology and clinical relevance. Anaesthesia 2005;60:565-74. [PMID: 15918828 DOI: 10.1111/j.1365-2044.2005.04192.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
35
DeLoughery TG. Venous Thromboembolism in the ICU and Reversal of Bleeding on Anticoagulants. Crit Care Clin 2005;21:497-512. [PMID: 15992670 DOI: 10.1016/j.ccc.2005.05.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
36
Bates SM, Weitz JI. New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin. Br J Pharmacol 2005;144:1017-28. [PMID: 15711585 PMCID: PMC1576097 DOI: 10.1038/sj.bjp.0706153] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2004] [Revised: 11/17/2004] [Accepted: 12/13/2004] [Indexed: 11/09/2022]  Open
37
Lee AYY. Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 2005;128:291-302. [PMID: 15667530 DOI: 10.1111/j.1365-2141.2004.05292.x] [Citation(s) in RCA: 78] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
38
Dahlbäck B. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med 2005;257:209-23. [PMID: 15715678 DOI: 10.1111/j.1365-2796.2004.01444.x] [Citation(s) in RCA: 110] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
39
Rosovsky RP, Kuter DJ. Catheter-Related Thrombosis in Cancer Patients: Pathophysiology, Diagnosis, and Management. Hematol Oncol Clin North Am 2005;19:183-202, vii. [PMID: 15639113 DOI: 10.1016/j.hoc.2004.09.007] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
40
Haas S. Oral direct thrombin inhibition: an effective and novel approach for venous thromboembolism. Drugs 2004;64 Suppl 1:7-16. [PMID: 15586623 DOI: 10.2165/00003495-200464001-00003] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
41
Planes A. Prevention of venous thromboembolism after orthopedic surgery: the EXPRESS study. J Thromb Haemost 2004. [DOI: 10.1111/j.1538-7836.2004.01008.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
42
Dobesh PP. Ximelagatran: Pharmacology, Pharmacokinetics, and Pharmacodynamics. Pharmacotherapy 2004;24:169S-178S. [PMID: 15624336 DOI: 10.1592/phco.24.15.169s.43160] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
43
Nutescu EA, Spinler SA, Dager WE, Bussey HI. Transitioning from Traditional to Novel Anticoagulants: The Impact of Oral Direct Thrombin Inhibitors on Anticoagulation Management. Pharmacotherapy 2004;24:199S-202S. [PMID: 15624340 DOI: 10.1592/phco.24.15.199s.43159] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
44
Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med 2004;10:356-65. [PMID: 15316432 DOI: 10.1097/01.mcp.0000136947.31517.c4] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
45
Gustafsson D, Bylund R, Antonsson T, Nilsson I, Nyström JE, Eriksson U, Bredberg U, Teger-Nilsson AC. A new oral anticoagulant: the 50-year challenge. Nat Rev Drug Discov 2004;3:649-59. [PMID: 15286732 DOI: 10.1038/nrd1466] [Citation(s) in RCA: 91] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
46
Guo H, Shaheen W, Kerber R, Olshansky B. Cardioversion of atrial tachyarrhythmias: anticoagulation to reduce thromboembolic complications. Prog Cardiovasc Dis 2004;46:487-505. [PMID: 15224256 DOI: 10.1016/j.pcad.2003.12.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
47
Ezekowitz MD, Falk RH. The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clin Proc 2004;79:904-13. [PMID: 15244388 DOI: 10.4065/79.7.904] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
48
Donnan GA, Dewey HM, Chambers BR. Warfarin for atrial fibrillation: the end of an era? Lancet Neurol 2004;3:305-8. [PMID: 15099545 DOI: 10.1016/s1474-4422(04)00738-0] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
49
Kuter DJ. Thrombotic Complications of Central Venous Catheters in Cancer Patients. Oncologist 2004;9:207-16. [PMID: 15047925 DOI: 10.1634/theoncologist.9-2-207] [Citation(s) in RCA: 144] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
50
Warkentin TE. Bivalent direct thrombin inhibitors: hirudin and bivalirudin. Best Pract Res Clin Haematol 2004;17:105-25. [PMID: 15171961 DOI: 10.1016/j.beha.2004.02.002] [Citation(s) in RCA: 101] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
PrevPage 1 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA